Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00733824 · ClinicalTrials.gov registry record · Phase 1

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

A Phase 1 study of Lymphoma, Non-Hodgkin and Hodgkin Disease, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 1
Development phase
61
Enrollment target
1
Study location

NCT00733824 is a Phase 1 study of Lymphoma, Non-Hodgkin and Hodgkin Disease that has completed, run by Washington University School of Medicine. The registered enrollment target is 61 participants, below the 393-participant average among 56 other Lymphoma, Non-Hodgkin trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00733824, a Phase 1 study of Lymphoma, Non-Hodgkin and Hodgkin Disease, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 1
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the safety and efficacy of intravenous AMD3100 added to a standard G-CSF mobilization regimen of patients undergoing autologous stem cell transplantation for lymphoma. The investigators hypothesize that after stem cell mobilization with G-CSF plus IV AMD3100, a significantly higher proportion of lymphoma patients will collect ≥ 2 x 10E6 CD34+ cells/kg.

Conditions Studied

Lymphoma, Non-Hodgkin Hodgkin Disease

Interventions

  • DRUG G-CSF
  • PROCEDURE Apheresis
  • DRUG AMD3100

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2008-11
Est. Completion 2013-09
Phase Phase 1

Sponsor

Washington University School of Medicine

1,502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00733824

The ClinicalTrials.gov registry entry for NCT00733824 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 56 other Lymphoma, Non-Hodgkin trials with a reported enrollment target (84% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lymphoma, Non-Hodgkin appearing as the primary indexed condition, and to 3 interventions - of which G-CSF is the first listed.

NCT00733824 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00733824 about?

NCT00733824 is a clinical study titled "Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma". This study will evaluate the safety and efficacy of intravenous AMD3100 added to a standard G-CSF mobilization regimen of patients undergoing autologous stem cell transplantation for lymphoma. The investigators hypothesize that after stem cell mobilization with G-CSF plus IV AMD3100, a significantl...

What is the current status of trial NCT00733824?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2008-11. Estimated completion is 2013-09.

What conditions does trial NCT00733824 study?

This clinical trial studies the following conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease.

What interventions are being tested in trial NCT00733824?

The interventions under investigation include: G-CSF (DRUG), Apheresis (PROCEDURE), AMD3100 (DRUG).

Who is sponsoring clinical trial NCT00733824?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00733824 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma, Non-Hodgkin

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lymphoma, Non-Hodgkin

All registered trials for this condition

Hodgkin Disease

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.